Stem cell expansion in animal-free conditions represents a major challenge for the production of human cell therapy products. To date, Fetal Bovine Serum
(FBS) is still widely used in many clinical-grade culture laboratories as growth supplement for cell culture.
Replacing FBS with human Platelet Lysate (hPL) allows for expansion and potential clinical-grade production of stem cells by eliminating the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens.
Human Platelet Lysate contains abundant growth factors and cytokines derived from human platelets which have been shown to stimulate cellular proliferation and maintain phenotype and differentation potential of human stem cells.
PL BioScience offers a standardized, Xenogeneic-free and GMP-conform human Platelet Lysate to close the gap between basic research & clinics.